Local thrombolysis in the management of acute cerebral ischemia.

Standard

Local thrombolysis in the management of acute cerebral ischemia. / Zeumer, Hermann.

in: ARZNEIMITTEL-FORSCH, Jahrgang 41, Nr. 3, 3, 1991, S. 352-354.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Zeumer H. Local thrombolysis in the management of acute cerebral ischemia. ARZNEIMITTEL-FORSCH. 1991;41(3):352-354. 3.

Bibtex

@article{64282e2246564e1f9237eb5846eb6de6,
title = "Local thrombolysis in the management of acute cerebral ischemia.",
abstract = "Local intraarterial fibrinolytic therapy (LIF) in patients with acute vertebrobasilar occlusion (AVBO) is a rational and, if successful, life saving treatment. The recent progress in this field is determined by the use of microcatheters for superselective basilar artery catheterisation and a {"}short-time, high-dose{"} regimen using 750,000 IU urokinase in not more than 2 h. Two out of 7 patients died and 1 did not improve to a better than a locked-in-state. Four patients, however, survived with excellent outcome.",
author = "Hermann Zeumer",
year = "1991",
language = "Deutsch",
volume = "41",
pages = "352--354",
number = "3",

}

RIS

TY - JOUR

T1 - Local thrombolysis in the management of acute cerebral ischemia.

AU - Zeumer, Hermann

PY - 1991

Y1 - 1991

N2 - Local intraarterial fibrinolytic therapy (LIF) in patients with acute vertebrobasilar occlusion (AVBO) is a rational and, if successful, life saving treatment. The recent progress in this field is determined by the use of microcatheters for superselective basilar artery catheterisation and a "short-time, high-dose" regimen using 750,000 IU urokinase in not more than 2 h. Two out of 7 patients died and 1 did not improve to a better than a locked-in-state. Four patients, however, survived with excellent outcome.

AB - Local intraarterial fibrinolytic therapy (LIF) in patients with acute vertebrobasilar occlusion (AVBO) is a rational and, if successful, life saving treatment. The recent progress in this field is determined by the use of microcatheters for superselective basilar artery catheterisation and a "short-time, high-dose" regimen using 750,000 IU urokinase in not more than 2 h. Two out of 7 patients died and 1 did not improve to a better than a locked-in-state. Four patients, however, survived with excellent outcome.

M3 - SCORING: Zeitschriftenaufsatz

VL - 41

SP - 352

EP - 354

IS - 3

M1 - 3

ER -